ESCMID PK/PD of Anti-Infectives Study Group - EPASG

News & Activities

New EPASG Executive Committee elected

A new EPASG Executive Committee has been elected and will now be:

  • Markus Zeitlinger, Austria (Chair)
  • Thomas Tängdén, Sweden (Secretary)
  • Birgit Koch, Netherlands (Treasurer)
  • Sebastian Wicha, Germany (Education Officer)
  • Francoise Van Bambeke, Belgium (Science Officer)

We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.

You can find the full election report here

EPASG Anti COVID-19 Survey

EPASG invites you to answer a short questionnaire with the aim of evaluating your actual "standard of care" for anti COVID-19 therapy use in your country and your department. The survey will allow us to assess the different practices worldwide for participants with direct patient care.

It will take no more than 10 minutes to complete this important survey to improve COVID-19 treatment. Do not hesitate, click here to participate!

ESCMID Postgraduate Education Course

Optimised Dosing of Antibiotics

Understanding PK/PD, Clinical Breakpoints and Therapeutic Drug Monitoring

Organised by EPASG, ESCMID, EUCAST and the International Society of Anti-Infectives Pharmacology (ISPA)

Rotterdam, Netherlands 11 – 12 April 2019


Course material in the ESCMID eLibrary

ESCMID Postgraduate Education Course

Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic


25 – 28 September 2018, Bochum, Germany


Course material in the ESCMID eLibrary